BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

780 related articles for article (PubMed ID: 35568116)

  • 21. MicroRNA miR-509-3p inhibit metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma.
    Zhang H; Liu S; Chen L; Sheng Y; Luo W; Zhao G
    Bioengineered; 2021 Dec; 12(1):2263-2273. PubMed ID: 34115554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.
    Wang LP; Lin J; Ma XQ; Xu DY; Shi CF; Wang W; Jiang XJ
    J Exp Clin Cancer Res; 2021 May; 40(1):177. PubMed ID: 34039401
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomal miR-4800-3p Aggravates the Progression of Hepatocellular Carcinoma
    Lin H; Peng J; Zhu T; Xiong M; Zhang R; Lei L
    Front Oncol; 2022; 12():759864. PubMed ID: 35756606
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating RNA ZFR promotes hepatocellular carcinoma cell proliferation and epithelial-mesenchymal transition process through miR-624-3p/WEE1 axis.
    Zhang L; He S; Guan H; Zhao Y; Zhang D
    Hepatobiliary Pancreat Dis Int; 2024 Feb; 23(1):52-63. PubMed ID: 37516591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of miR-541-3p/TMPRSS4 in the metastasis and EMT of hepatocellular carcinoma.
    Xia YH; Ren L; Li JZ; Gao F
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10721-10728. PubMed ID: 31858539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.
    He Y; He X
    Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MicroRNA-3194-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yao B; Li Y; Wang L; Chen T; Niu Y; Liu Q; Liu Z
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3885-3895. PubMed ID: 31561723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Catalpol inhibits cell proliferation, invasion and migration through regulating miR-22-3p/MTA3 signalling in hepatocellular carcinoma.
    Zhao L; Wang Y; Liu Q
    Exp Mol Pathol; 2019 Aug; 109():51-60. PubMed ID: 31145886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome-Mediated MiR-155 Transfer Contributes to Hepatocellular Carcinoma Cell Proliferation by Targeting PTEN.
    Sun JF; Zhang D; Gao CJ; Zhang YW; Dai QS
    Med Sci Monit Basic Res; 2019 Oct; 25():218-228. PubMed ID: 31645540
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MicroRNA-148a-3p inhibits progression of hepatocelluar carcimoma by repressing SMAD2 expression in an Ago2 dependent manner.
    Huang Z; Wen J; Yu J; Liao J; Liu S; Cai N; Liang H; Chen X; Ding Z; Zhang B
    J Exp Clin Cancer Res; 2020 Aug; 39(1):150. PubMed ID: 32746934
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-1301 inhibits hepatocellular carcinoma cell migration, invasion, and angiogenesis by decreasing Wnt/β-catenin signaling through targeting BCL9.
    Yang C; Xu Y; Cheng F; Hu Y; Yang S; Rao J; Wang X
    Cell Death Dis; 2017 Aug; 8(8):e2999. PubMed ID: 28817119
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylation-associated silencing of microRNA-129-3p promotes epithelial-mesenchymal transition, invasion and metastasis of hepatocelluar cancer by targeting Aurora-A.
    Cui S; Zhang K; Li C; Chen J; Pan Y; Feng B; Lu L; Zhu Z; Wang R; Chen L
    Oncotarget; 2016 Nov; 7(47):78009-78028. PubMed ID: 27793005
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-128-3p suppresses tumor proliferation and metastasis via targeting CDC6 in hepatocellular carcinoma cells.
    Shi Y; Yan F; Wang F; Pan L
    Tissue Cell; 2021 Oct; 72():101534. PubMed ID: 33991762
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosome-transmitted miR-128-3p increase chemosensitivity of oxaliplatin-resistant colorectal cancer.
    Liu T; Zhang X; Du L; Wang Y; Liu X; Tian H; Wang L; Li P; Zhao Y; Duan W; Xie Y; Sun Z; Wang C
    Mol Cancer; 2019 Mar; 18(1):43. PubMed ID: 30890168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-92a-3p Promotes the Malignant Progression of Hepatocellular Carcinoma by Mediating the PI3K/AKT/mTOR Signaling Pathway.
    Wang L; Cui M; Qu F; Cheng D; Yu J; Tang Z; Cheng L; Wei Y; Wu X; Liu X
    Curr Pharm Des; 2021; 27(29):3244-3250. PubMed ID: 34126886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression.
    Qu W; Wen X; Su K; Gou W
    J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exosome-mediated transfer of circRNA563 promoting hepatocellular carcinoma by targeting the microRNA148a-3p/metal-regulatory transcription factor-1 pathway.
    Lyu ZZ; Li M; Yang MY; Han MH; Yang Z
    World J Gastroenterol; 2023 Dec; 29(46):6060-6075. PubMed ID: 38130740
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA miR-124-3p suppresses proliferation and epithelial-mesenchymal transition of hepatocellular carcinoma via ARRDC1 (arrestin domain containing 1).
    Zhao Q; Jiang F; Zhuang H; Chu Y; Zhang F; Wang C
    Bioengineered; 2022 Apr; 13(4):8255-8265. PubMed ID: 35300565
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exosomal LINC00161 promotes angiogenesis and metastasis via regulating miR-590-3p/ROCK axis in hepatocellular carcinoma.
    You LN; Tai QW; Xu L; Hao Y; Guo WJ; Zhang Q; Tong Q; Zhang H; Huang WK
    Cancer Gene Ther; 2021 Jun; 28(6):719-736. PubMed ID: 33414518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.